Hematological particularities and co-infections in injected drug users with AIDS
Autor(a) principal: | |
---|---|
Data de Publicação: | 2013 |
Outros Autores: | , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Brazilian Journal of Infectious Diseases |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702013000600005 |
Resumo: | HIV patients infected through injected drug use have poorer prognosis than other groups. We evaluated the hematological alterations and rates of co-infections in injected drug use patients with AIDS. Injected drug use patients were younger, predominantly of male gender, and presented lower CD4, total lymphocyte, and platelet counts, but not neutrophil count, than control group. Injected drug use patients had a higher rate of hepatitis C and mycobacteria infection. Furthermore, all injected drug use patients with hemoglobin <10.0 g dL-1 and lymphocyte <1000 µL-1 had CD4 count lower than 100 µL-1. In conclusion, HIV-infected injected drug use patients constitute a special group of patients, and hemoglobin concentration and lymphocyte count can be used as surrogate markers for disease severity. |
id |
BSID-1_7a7466d057cebd75cc4733a12305e27e |
---|---|
oai_identifier_str |
oai:scielo:S1413-86702013000600005 |
network_acronym_str |
BSID-1 |
network_name_str |
Brazilian Journal of Infectious Diseases |
repository_id_str |
|
spelling |
Hematological particularities and co-infections in injected drug users with AIDSAIDSInjected drug useAnemiaHCVMycobacteriaHIV patients infected through injected drug use have poorer prognosis than other groups. We evaluated the hematological alterations and rates of co-infections in injected drug use patients with AIDS. Injected drug use patients were younger, predominantly of male gender, and presented lower CD4, total lymphocyte, and platelet counts, but not neutrophil count, than control group. Injected drug use patients had a higher rate of hepatitis C and mycobacteria infection. Furthermore, all injected drug use patients with hemoglobin <10.0 g dL-1 and lymphocyte <1000 µL-1 had CD4 count lower than 100 µL-1. In conclusion, HIV-infected injected drug use patients constitute a special group of patients, and hemoglobin concentration and lymphocyte count can be used as surrogate markers for disease severity.Brazilian Society of Infectious Diseases2013-12-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702013000600005Brazilian Journal of Infectious Diseases v.17 n.6 2013reponame:Brazilian Journal of Infectious Diseasesinstname:Brazilian Society of Infectious Diseases (BSID)instacron:BSID10.1016/j.bjid.2013.03.010info:eu-repo/semantics/openAccessBrunetta,Denise MenezesDe Santis,Gil CunhaVilar,Fernando CrivelentiBrandão,Renata AmorimMuniz,Renata Zomer de AlbernazLima,Geovana Momo Nogueira deAmorelli-Chacel,Manuela EmilianaCovas,Dimas TadeuMachado,Alcyone Artiolieng2015-06-26T00:00:00Zoai:scielo:S1413-86702013000600005Revistahttps://www.bjid.org.br/https://old.scielo.br/oai/scielo-oai.phpbjid@bjid.org.br||lgoldani@ufrgs.br1678-43911413-8670opendoar:2015-06-26T00:00Brazilian Journal of Infectious Diseases - Brazilian Society of Infectious Diseases (BSID)false |
dc.title.none.fl_str_mv |
Hematological particularities and co-infections in injected drug users with AIDS |
title |
Hematological particularities and co-infections in injected drug users with AIDS |
spellingShingle |
Hematological particularities and co-infections in injected drug users with AIDS Brunetta,Denise Menezes AIDS Injected drug use Anemia HCV Mycobacteria |
title_short |
Hematological particularities and co-infections in injected drug users with AIDS |
title_full |
Hematological particularities and co-infections in injected drug users with AIDS |
title_fullStr |
Hematological particularities and co-infections in injected drug users with AIDS |
title_full_unstemmed |
Hematological particularities and co-infections in injected drug users with AIDS |
title_sort |
Hematological particularities and co-infections in injected drug users with AIDS |
author |
Brunetta,Denise Menezes |
author_facet |
Brunetta,Denise Menezes De Santis,Gil Cunha Vilar,Fernando Crivelenti Brandão,Renata Amorim Muniz,Renata Zomer de Albernaz Lima,Geovana Momo Nogueira de Amorelli-Chacel,Manuela Emiliana Covas,Dimas Tadeu Machado,Alcyone Artioli |
author_role |
author |
author2 |
De Santis,Gil Cunha Vilar,Fernando Crivelenti Brandão,Renata Amorim Muniz,Renata Zomer de Albernaz Lima,Geovana Momo Nogueira de Amorelli-Chacel,Manuela Emiliana Covas,Dimas Tadeu Machado,Alcyone Artioli |
author2_role |
author author author author author author author author |
dc.contributor.author.fl_str_mv |
Brunetta,Denise Menezes De Santis,Gil Cunha Vilar,Fernando Crivelenti Brandão,Renata Amorim Muniz,Renata Zomer de Albernaz Lima,Geovana Momo Nogueira de Amorelli-Chacel,Manuela Emiliana Covas,Dimas Tadeu Machado,Alcyone Artioli |
dc.subject.por.fl_str_mv |
AIDS Injected drug use Anemia HCV Mycobacteria |
topic |
AIDS Injected drug use Anemia HCV Mycobacteria |
description |
HIV patients infected through injected drug use have poorer prognosis than other groups. We evaluated the hematological alterations and rates of co-infections in injected drug use patients with AIDS. Injected drug use patients were younger, predominantly of male gender, and presented lower CD4, total lymphocyte, and platelet counts, but not neutrophil count, than control group. Injected drug use patients had a higher rate of hepatitis C and mycobacteria infection. Furthermore, all injected drug use patients with hemoglobin <10.0 g dL-1 and lymphocyte <1000 µL-1 had CD4 count lower than 100 µL-1. In conclusion, HIV-infected injected drug use patients constitute a special group of patients, and hemoglobin concentration and lymphocyte count can be used as surrogate markers for disease severity. |
publishDate |
2013 |
dc.date.none.fl_str_mv |
2013-12-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702013000600005 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702013000600005 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1016/j.bjid.2013.03.010 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Brazilian Society of Infectious Diseases |
publisher.none.fl_str_mv |
Brazilian Society of Infectious Diseases |
dc.source.none.fl_str_mv |
Brazilian Journal of Infectious Diseases v.17 n.6 2013 reponame:Brazilian Journal of Infectious Diseases instname:Brazilian Society of Infectious Diseases (BSID) instacron:BSID |
instname_str |
Brazilian Society of Infectious Diseases (BSID) |
instacron_str |
BSID |
institution |
BSID |
reponame_str |
Brazilian Journal of Infectious Diseases |
collection |
Brazilian Journal of Infectious Diseases |
repository.name.fl_str_mv |
Brazilian Journal of Infectious Diseases - Brazilian Society of Infectious Diseases (BSID) |
repository.mail.fl_str_mv |
bjid@bjid.org.br||lgoldani@ufrgs.br |
_version_ |
1754209242783416320 |